| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 1087034 | Le Pharmacien Hospitalier et Clinicien | 2011 | 7 Pages |
Abstract
RF seamed efficient to treat hepatic and kidney tumors but more investigation is needed for lung tumors. It is also necessary to determine the role of RF ablation among therapeutic options (chemotherapy, radiotherapy and surgery).
Keywords
Related Topics
Health Sciences
Pharmacology, Toxicology and Pharmaceutical Science
Pharmacology, Toxicology and Pharmaceutics (General)
Authors
K.-A. Phai Pang, P. Iooss, H. Dettloff, D. Roncalez,